8-K: Health In Tech Unveils AI-Powered Growth Strategy
Investor Presentation
Health In Tech, Inc. presented its AI-powered marketplace platform for self-funded health plans, reporting strong 2025 financial results and optimistic 2026 revenue guidance.
Summary
- Health In Tech, Inc. (HIT) operates an AI-powered marketplace platform designed to help Small & Medium Size Businesses (SMBs) access self-funded healthcare plans (SFPs).
- The company's proprietary eDIYBS software enables brokers to obtain bindable self-funded plan quotes in minutes, significantly reducing the traditional quoting time from 12 days to 3 months down to 2 minutes to 2 weeks.
- HIT's HI Performance Network provides nationwide coverage across 50 states with over 1.30 million provider locations, utilizing Medicare-based pricing to drive 20%+ average cost savings compared to traditional commercial rates.
- The business model is fee-driven, with no plan or underwriting risk exposure, generating recurring revenue from monthly administrative fees and a percentage of stop-loss gross premiums.
- For the full year 2025, total revenue grew 71% year-over-year to $33.3 million, and Adjusted EBITDA increased 81% year-over-year to $4.1 million.
- The company provided 2026 revenue guidance of $45 million to $50 million, representing approximately 43% year-over-year growth at the midpoint.
- As of December 31, 2025, HIT had clients in 40 states, serving 795 business clients and 22,515 enrolled employees, supported by over 850 brokers, TPAs, and other third-party agencies.
- Key growth pathways include monetizing proprietary data, introducing new products like a Three-Year Rate Stabilization Program, driving more Managing General Underwriters (MGUs) and carriers onto the platform, and increasing broker count.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this filing positively due to the strong revenue and Adjusted EBITDA growth in 2025, coupled with optimistic 2026 guidance. The company's innovative AI-powered platform addresses a significant market need with a de-risked business model, positioning it for continued expansion despite some Q4 profitability dips.
Positives
- Full year 2025 total revenue increased by 71% to $33.3 million, demonstrating strong growth.
- Full year 2025 Adjusted EBITDA grew by 81% to $4.1 million, indicating improved operational profitability.
- The company projects robust 2026 revenue guidance of $45 million to $50 million, representing approximately 43% year-over-year growth at the midpoint.
- HIT's business model is fee-driven with no plan or underwriting risk exposure, insulating it from claims or catastrophic losses.
- The eDIYBS software significantly reduces the time for brokers to get bindable self-funded plan quotes, enhancing efficiency and cost savings for SMBs.
- The HI Performance Network offers 20%+ average cost savings compared to traditional commercial rates through Medicare-based pricing.
- Accounts Receivable Days improved significantly from 29 days in 2024 to 14 days in 2025, indicating strong cash conversion.
- The company operates in a massive, under-penetrated market, with only 15-20% self-funded plan penetration for small businesses compared to 80% for large businesses.
Negatives
- Net income for Q4 2025 was a loss of $(0.3) million, compared to a loss of $(0.1) million in Q4 2024.
- Adjusted EBITDA for Q4 2025 decreased to $0.3 million from $0.5 million in Q4 2024.
- Gross Margin Percent declined to 55.0% in Q4 2025 from 77.4% in Q4 2024, and to 62.8% for FY 2025 from 79.2% for FY 2024.
Risks
- The company's liquidity position and ability to access capital.
- The company's ability to continue as a going concern.
- Employee attrition and the company's ability to retain senior management and other key personnel.
- The company's ability to enhance its existing products and services.
- Product and service quality issues.
- Market competition.
Future Outlook
Health In Tech, Inc. anticipates strong revenue growth in 2026, with guidance set between $45 million and $50 million, representing approximately 43% year-over-year growth at the midpoint. The company plans to achieve this through monetizing its proprietary data lake, introducing new products like a Three-Year Rate Stabilization Program, expanding its network of Managing General Underwriters (MGUs) and carriers, and increasing its broker count.
Management Comments
- The company is focused on increasing awareness and driving broker count in 2026 and beyond.
- Health In Tech's AI-powered solutions remove barriers, enabling SMBs to benefit from self-funded plans.
- The company's marketplace platform unites an ecosystem of vendors, and AI accelerates value inside the platform.
- HIT is the platform disruptors use to access the marketplace and deliver growth.
Industry Context
StockSavvy.ai notes that Health In Tech is strategically positioned to disrupt the traditional healthcare insurance market by addressing the significant complexity and under-penetration of self-funded plans among small and medium-sized businesses. While large businesses have an 80% penetration rate for self-funded plans, SMBs only reach 15-20%, indicating a substantial untapped market. The company's AI-powered platform and efficient quoting system directly tackle the barriers that have historically prevented SMBs from accessing the cost and flexibility benefits of SFPs, aligning with broader industry trends towards digital transformation and cost optimization in healthcare.
Comparison to Industry Standards
- Health In Tech's Medicare-based pricing model drives 20%+ average cost savings compared to traditional commercial rates, offering a significant competitive advantage in cost efficiency.
- The company's eDIYBS software reduces the time to generate bindable self-funded plan quotes from a typical 12 days to 3 months down to 2 minutes to 2 weeks, drastically outperforming legacy quoting procedures.
- The self-funded plan penetration for small businesses (15-20%) is significantly lower than for large businesses (80%), highlighting Health In Tech's focus on a largely underserved market segment compared to established industry norms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Listing Status | Securities registered pursuant to Section 12(b) of the Act: Class A Common Stock, $0.001 par value per share, trading symbol HIT, registered on The Nasdaq Stock Market LLC (Nasdaq Capital Market). | N/A | Maintains public market access and regulatory oversight, enhancing transparency and liquidity for investors. |
| Emerging Growth Company Status | The registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934, and has elected not to use the extended transition period for complying with new or revised financial accounting standards. | N/A | Indicates the company is subject to certain scaled disclosure requirements and exemptions, but has opted for earlier compliance with new accounting standards, potentially signaling a commitment to robust financial reporting. |
Stakeholder Impact
- Shareholders: Potential for significant capital appreciation due to strong growth, market disruption, and positive future outlook, balanced by inherent risks of an emerging growth company.
- Employees: Continued growth and expansion may lead to increased opportunities, but employee attrition is noted as a risk.
- Customers (SMBs): Benefit from access to cheaper, faster, and more flexible self-funded health plans, leading to cost savings and improved employee benefits.
- Brokers/TPAs: Provided with an efficient AI-powered platform (eDIYBS) to streamline quoting and plan administration, enhancing their service offerings and client acquisition.
- Carriers/MGUs: Opportunity to leverage HIT's platform and AI-enabled underwriting features to expand their reach and efficiency in the self-funded market.
Next Steps
- Monetizing proprietary data lake to enhance cross-selling opportunities and entry into new markets.
- Introducing novel new products such as a Three-Year Rate Stabilization Program and One Year Large Group plans.
- Driving more Managing General Underwriters (MGUs) and carriers onto the HIT platform to leverage AI-enabled underwriting features.
- Increasing broker count through the HIT in-house sales team in 2026 and beyond.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | End of fiscal year 2024, used for financial comparisons. |
| 2025-12-31 | End of fiscal year 2025, used for financial reporting and metrics. |
| 2026-03-25 | Date of the Current Report on Form 8-K and the investor presentation. |
| 2026-03-27 | Date the Form 8-K was signed by Health In Tech, Inc. |
Recommendation
strong buyHealth In Tech presents a compelling investment opportunity given its strong 71% revenue growth and 81% Adjusted EBITDA growth in FY 2025, coupled with an ambitious 2026 revenue guidance of 43% year-over-year growth at the midpoint. The company's AI-powered platform effectively addresses a massive, under-penetrated market for self-funded health plans among SMBs, offering a de-risked, fee-based business model with no underwriting exposure. While Q4 2025 showed some minor profitability dips, the overall trajectory, innovative technology, and clear growth strategies position HIT for significant market share capture and sustained expansion. The improved cash conversion further strengthens its operational efficiency, making it a strong buy for investors seeking exposure to disruptive healthcare technology.
Keywords
Health In Tech, HIT, AI-powered marketplace, Self-funded health plans, SMB healthcare, Healthcare technology, Insurance innovation, eDIYBS, HI Performance Network, Health insurance marketplace, Corporate wellness, Employee benefits
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.